The University of Sydney Northern Clinical School, Women and Babies Research, St Leonards, New South Wales, Australia
Northern Sydney Local Health District, Kolling Institute, St Leonards, New South Wales, Australia.
BMJ Open Diabetes Res Care. 2021 Jun;9(1). doi: 10.1136/bmjdrc-2021-002277.
The incidence of gestational diabetes mellitus (GDM) is increasing in Australia, influenced by changed diagnostic criteria. We aimed to identify whether the diagnostic change was associated with improved outcomes and/or increased obstetric interventions using state-wide data in New South Wales (NSW), Australia.
Perinatal and hospital data were linked for singleton births, 33-41 weeks' gestation, 2006-2015, NSW. An adjusted Poisson model was used to split pregnancies from 2011 onwards into those that would have been diagnosed under the old criteria ('previous GDM') and newly diagnosed cases ('additional GDM'). We compared actual rates of total and early (<39 weeks) planned births, cesareans, and maternal and neonatal adverse outcomes for GDM-diagnosed pregnancies using three predicted scenarios, where the 'additional GDM' group was assumed to have the same rates as: the 'previous GDM' group <2011 (scenario A); the 'non-GDM' group <2011 (scenario B); or the 'non-GDM' group ≥2011 (scenario C).
GDM incidence more than doubled over the study period, with an inflection point observed at 2011. For those diagnosed with GDM since 2011, the actual incidence of interventions (planned births and cesareans) and macrosomia was consistent with scenario A, which meant higher intervention rates, but lower rates of macrosomia, than those with no GDM. Incidence of neonatal hypoglycemia was lower than scenario A and closer to the other scenarios. There was a reduction in perinatal deaths among those with GDM, lower than that predicted by all scenarios, indicating an improvement for all with GDM, not only women newly diagnosed. Incidence of maternal and neonatal morbidity indicators was within the confidence bounds for all three predicted scenarios.
Our study suggests that the widely adopted new diagnostic criteria for GDM are associated with increased obstetric intervention rates and lower rates of macrosomic babies, but with no clear impacts on maternal or neonatal morbidity.
在澳大利亚,由于诊断标准的改变,妊娠糖尿病(GDM)的发病率正在上升。我们旨在使用澳大利亚新南威尔士州(NSW)的全州数据,确定诊断标准的改变是否与改善结局和/或增加产科干预有关。
将 2006-2015 年 33-41 周龄单胎妊娠的围产期和医院数据进行链接。使用调整后的泊松模型将 2011 年以后的妊娠分为旧标准诊断的妊娠(“既往 GDM”)和新诊断的病例(“新增 GDM”)。我们使用三种预测情况比较了 GDM 诊断妊娠的总产和早期(<39 周)计划分娩、剖宫产率以及母婴不良结局的实际发生率,其中“新增 GDM”组被假设具有与以下情况相同的比率:2011 年以前的“既往 GDM”组(情况 A);2011 年以前的“非 GDM”组(情况 B);或 2011 年以后的“非 GDM”组(情况 C)。
研究期间 GDM 的发病率增加了一倍以上,2011 年出现拐点。对于自 2011 年以来被诊断为 GDM 的患者,干预措施(计划分娩和剖宫产)和巨大儿的实际发生率与情况 A 一致,这意味着干预率较高,但巨大儿的发生率低于非 GDM 患者。新生儿低血糖的发生率低于情况 A,更接近其他情况。GDM 患者的围产儿死亡率有所下降,低于所有情况的预测值,这表明所有 GDM 患者,而不仅仅是新诊断的患者,都有所改善。母婴发病率指标的发生率在所有三种预测情况的置信区间内。
我们的研究表明,广泛采用的 GDM 新诊断标准与产科干预率的增加和巨大儿婴儿的发生率降低有关,但对母婴发病率没有明显影响。